Univ.-Ass. Dr. Katharina Kieslich, BA MA

Erreichbarkeit

Neues Institutsgebäude
Universitätsstr. 7/2. Stock
Zi.-Nr.: B 219
1010 Wien
T: +43-1-4277-494 10
F: +43-1-4277-949 4
E-Mail: katharina.kieslich@univie.ac.at

Sprechstunde

Nach Vereinbarung

Kurzbiographie

• Studium der Internationalen Beziehungen und Rechtswissenschaften (University of Plymouth, BSc 2005).
• Studium der Nahostwissenschaften (University of Exeter, MA 2006).
• Promotion im Fachbereich Politikwissenschaft bei Prof. Albert Weale, Doktorarbeit zur Arzneimittelbewertung: „Paradigms in Operation: Pharmaceutical Benefit Assessments in England and Germany“ (University College London, 2010-2015).
• Praktikum an der Ständigen Vertretung der Bundesrepublik Deutschland bei den Vereinten Nationen (New York, 2004).
• Wissenschaftliche Referentin der CDU-Bürgerschaftsfraktion (Bremen, 2007-2010).
• Research Fellow in Health Policy am King’s College London (2014-2018).

Forschungsschwerpunkte

Vergleichende Gesundheitspolitik; Vergleichende Policy-Forschung; Priorisierung und Rationierung im Gesundheitswesen; Health technology assessment (HTA); Rolle von gesellschaftlichen Werten in Priorisierungsprozessen im Gesundheitswesen; Bürgerbeteiligung in gesundheitspolitischen Entscheidungen.

Auswahlbibliographie

  •  Charlton, V., Littlejohns, P., Kieslich, K., Mitchell, P., Rumbold, B., Weale, A., Wilson, J. and Rid, A. (2017) “Cost effective but unaffordable: an emerging challenge for health systems”, BMJ, 356:j1402. DOI: 10.1136/bmj.j1402
  • Kieslich, K., Bump, JB., Norheim, OF., Tantivess, S., Littlejohns, P. (2016) “Accounting for Technical, Ethical, and Political Factors in Priority Setting”, Health Systems & Reform, Vol. 2 No. 1, pp. 51-60.
  • Littlejohns, P., Weale, A., Kieslich, K., Wilson, J., Rumbold, B., Max, C. and Rid, A. (2016) “Challenges for the new Cancer Drugs Fund”, The Lancet Oncology, Vol. 17 No. 4, pp. 416-418. DOI: http://dx.doi.org/10.1016/S1470-2045(16)00100-5
  • Kieslich, K., Littlejohns, P. and Weale, A. (2016) “NHS limiting access to high priced
    drugs: Drug appraisal issues must be resolved at policy level”, BMJ, 354:i4519. DOI: 10.1136/bmj.i4519
  • Kieslich, K., Ahn, J., Badano, G., Chalkidou, K., Cubillos, L., Hauegen, RC., Henshall, C., Krubiner, C., Littlejohns, P., Lu, L., Pearson, S., Rid, A., Whitty, JA, Wilson, J. (2016) “Public Participation in Decision-Making on the Coverage of New Antivirals for Hepatitis C”, Journal of Health Organization and Management, Vol. 30 No. 5, pp. 769-785.
  • Hunter, DJ., Kieslich, K., Littlejohns, P., Staniszewska, S., Tumilty, E., Weale, A. and Williams, I. (2016) “Public Involvement in Health Priority Setting: Future Challenges for Policy, Research and Society”, Journal of Health Organization and Management, Vol. 30 No. 5, pp. 796-808.
  • Littlejohns, P., Knight, A., Littlejohns, A., Poole, TL. and Kieslich, K. (2016) “Setting standards and monitoring quality in the NHS 1999-2013”, International Journal of Health Planning and Management, DOI: 10.1002/hpm.2365
  • Weale, A., Kieslich, K., Littlejohns, P., Tugendhaft, A., Tumilty, E., Weerasuriya, K. and Whitty, JA. (2016) “Introduction: Priority Setting, Equitable Access and Public
    Involvement in Health Care”, Journal of Health Organization and Management, Vol. 30 No. 5, pp. 736-750.
  • Kieslich, K. and Littlejohns. P. (2015) “Does accountability for reasonableness work? A protocol for a mixed methods study using an audit tool to evaluate the decision-making of clinical commissioning groups in England”, BMJ Open, 5:e007908. DOI:10.1136/bmjopen-2015-007908
  • Rid, A., Littlejohns, P., Wilson, J., Rumbold, B., Kieslich, K. and Weale, A. (2015) “The importance of being NICE”, Journal of the Royal Society of Medicine, Vol. 108 No. 10, pp. 385-389.
  • Kieslich, K. (2012) “Social values and health priority setting in Germany”, Journal of
    Health Organization and Management, Vol. 26 No. 3, pp. 374-383.

Zurück